CUX1 and IκBζ (NFKBIZ) mediate the synergistic inflammatory response to TNF and IL-17A in stromal fibroblasts
- 20 February 2020
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 117 (10), 5532-5541
- https://doi.org/10.1073/pnas.1912702117
Abstract
The role of stromal fibroblasts in chronic inflammation is unfolding. In rheumatoid arthritis, leukocyte-derived cytokines TNF and IL-17A work together, activating fibroblasts to become a dominant source of the hallmark cytokine IL-6. However, IL-17A alone has minimal effect on fibroblasts. To identify key mediators of the synergistic response to TNF and IL-17A in human synovial fibroblasts, we performed time series, dose–response, and gene-silencing transcriptomics experiments. Here we show that in combination with TNF, IL-17A selectively induces a specific set of genes mediated by factors including cut-like homeobox 1 (CUX1) and IκBζ (NFKBIZ). In the promoters of CXCL1, CXCL2, and CXCL3, we found a putative CUX1–NF-κB binding motif not found elsewhere in the genome. CUX1 and NF-κB p65 mediate transcription of these genes independent of LIFR, STAT3, STAT4, and ELF3. Transcription of NFKBIZ, encoding the atypical IκB factor IκBζ, is IL-17A dose-dependent, and IκBζ only mediates the transcriptional response to TNF and IL-17A, but not to TNF alone. In fibroblasts, IL-17A response depends on CUX1 and IκBζ to engage the NF-κB complex to produce chemoattractants for neutrophil and monocyte recruitment.Keywords
Funding Information
- HHS | National Institutes of Health (U01GM092691)
- HHS | National Institutes of Health (R01AR063709)
- HHS | National Institutes of Health (F31AR070582)
- HHS | National Institutes of Health (T32HL007627)
- National Institutes of Health (RO1AR073833)
This publication has 60 references indexed in Scilit:
- Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practiceRMD Open, 2017
- 30 Years of NF-κB: A Blossoming of Relevance to Human PathobiologyCell, 2017
- Near-optimal probabilistic RNA-seq quantificationNature Biotechnology, 2016
- The IL-23–IL-17 axis in inflammatory arthritisNature Reviews Rheumatology, 2015
- Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressorsNature Reviews Rheumatology, 2012
- The IL‐17 pathway as a major therapeutic target in autoimmune diseasesAnnals of the New York Academy of Sciences, 2010
- Identification of NR4A2 as a transcriptional activator of IL-8 expression in human inflammatory arthritisMolecular Immunology, 2009
- Genome-Wide Comparison between IL-17A- and IL-17F-Induced Effects in Human Rheumatoid Arthritis SynoviocytesThe Journal of Immunology, 2009
- Exploration, normalization, and summaries of high density oligonucleotide array probe level dataBiostatistics, 2003
- Granulocyte survival in synovial exudate of patients with rheumatoid arthritis and other inflammatory joint diseases.1967